TAVR, Sapien 3, ACC.16
Feature | Heart Valve Technology | Michael J. Rinaldi, M.D., FACC, FSCAI

The continuation of positive clinical trial data for transcatheter aortic valve repair (TAVR), showing it is equal to or ...

Home April 19, 2016
Home
News | Heart Failure

In one of the largest trials ever conducted of heart failure patients with reduced ejection fraction, the investigational drug aliskiren failed to show superiority over full-dose treatment with the existing “gold standard” therapy angiotensin-converting enzyme (ACE) inhibitor enalapril.

Home April 19, 2016
Home
Technology | EP Mapping and Imaging Systems

St. Jude Medical Inc. announced expansion of its EnSite Precision cardiac mapping system limited market release in Europe.

Home April 19, 2016
Home
News | Cath Lab

A large randomized controlled trial of ischemic postconditioning in patients who had experienced ST-segment elevation myocardial infarction (STEMI) failed to show the procedure significantly reduces death from any cause or hospitalization for heart failure.

Home April 19, 2016
Home
News | Sudden Cardiac Arrest

April 19, 2016 — Researchers have confirmed that certain heart rhythm medications, when given by paramedics to patients ...

Home April 19, 2016
Home
News | Cath Lab

Delayed or deferred stent implantation in patients showed no clinical benefit in patients experiencing the deadliest form of heart attack, ST-segment elevation myocardial infarction (STEMI), according to research presented at the American College of Cardiology’s 65th Annual Scientific Session (ACC.16).

Home April 18, 2016
Home
Technology | Cardiac Resynchronization Therapy Devices (CRT)

St. Jude Medical Inc. announced the U.S. launch and first U.S. implants of the Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D) with MultiPoint Pacing Technology.

Home April 18, 2016
Home
News | Peripheral Artery Disease (PAD)

The American College of Radiology (ACR), as a member of a coalition of leading medical societies, provided peripheral arterial disease (PAD) treatment recommendations to the Medicare Evidence Development Coverage Advisory Committee (MEDCAC).

Home April 18, 2016
Home
FFR-CT, heartflow
Feature | CT Angiography (CTA) | Jeff Zagoudis

Fractional flow reserve-computed tomography (FFR-CT) is still in the early stages of clinical implementation in the ...

Home April 15, 2016
Home
Inventory management, analytics software, cardiology
Feature | Analytics Software | Dave Fornell

With all areas of healthcare now migrating to electronic medical record (EMR) platforms, the data they contain can be ...

Home April 15, 2016
Home
Sponsored Content | Videos | Inventory Management

Healthcare reform is changing the way you provide care. With a focus on cost efficiency and quality, tracking ...

Home April 15, 2016
Home
Sapien III, Sapien 3, PARTNER II
Feature | Heart Valve Technology

April 15, 2016 — Intermediate-risk patients who received transcatheter aortic valve replacement (TAVR) with the latest ...

Home April 15, 2016
Home
Technology | ECG Management Systems

GE Healthcare released its new MUSE ECG management platform, MUSE v9, at the American College of Cardiology (ACC) 2016 ...

Home April 15, 2016
Home
News | Heart Failure

April 15, 2016 — An investigational stem cell therapy derived from patients’ own blood marrow significantly improved ...

Home April 15, 2016
Home
TAVR runoff image
Feature | Heart Valve Technology

April 15, 2016 — Accurate and precise anatomical information is crucial to successful transcatheter aortic valve ...

Home April 15, 2016
Home
Subscribe Now